Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response
Lung Cancer International · 2014
DOI: 10.1155/2014/731925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung Cancer International, 2014. Verfasst von Derek Grose und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beatson Oncology Centre, 1053 Great Western Road, Glasgow G12 0YN, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: West of Scotland Lung Cancer Group.
Abstract (Originalsprache)
Background
Prediction of survival in patients diagnosed with lung cancer remains problematical. The aim of the present study was to examine the clinical utility of an established objective marker of the systemic inflammatory response, the Glasgow Prognostic Score, as the basis of risk stratification in patients with lung cancer.
Methods
Between 2005 and 2008 all newly diagnosed lung cancer patients coming through the multidisciplinary meetings (MDTs) of four Scottish centres were included in the study. The details of 882 patients with a confirmed new diagnosis of any subtype or stage of lung cancer were collected prospectively.
Results
The median survival was 5.6 months (IQR 4.8–6.5). Survival analysis was undertaken in three separate groups based on mGPS score. In the mGPS 0 group the most highly predictive factors were performance status, weight loss, stage of NSCLC, and palliative treatment offered. In the mGPS 1 group performance status, stage of NSCLC, and radical treatment offered were significant. In the mGPS 2 group only performance status and weight loss were statistically significant.
Discussion
This present study confirms previous work supporting the use of mGPS in predicting cancer survival; however, it goes further by showing how it might be used to provide more objective risk stratification in patients diagnosed with lung cancer.
Autor:innen und Institutionen
- Beatson Oncology Centre, 1053 Great Western Road, Glasgow G12 0YN, UK.
- University of Aberdeen, Aberdeen, UK.
- Inverclyde Royal Hospital, Inverclyde, UK.
- Queen Margaret Hospital, Dunfermline, UK.
- University of Glasgow, Glasgow, UK.
- Glasgow Royal Infirmary, Glasgow, UK.
ORCID-Profile: Derek Grose, Richard Jones, Kirsty Docherty, David McIntosh
Förderung
- West of Scotland Lung Cancer Group
Zitieren
APA
Grose, D., Devereux, G., Brown, L., Jones, R., Sharma, D., Selby, C., Morrison, D. S., Docherty, K., McIntosh, D., McElhinney, P., Nicolson, M., McMillan, D. C., & Milroy, R. (2014). Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response. Lung Cancer International. https://doi.org/10.1155/2014/731925
Vancouver
Grose D, Devereux G, Brown L, Jones R, Sharma D, Selby C, et al. Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response. Lung Cancer International. 2014. doi:10.1155/2014/731925
BibTeX
@article{Grose2014,
author = {Grose, Derek and Devereux, Graham and Brown, Louise and Jones, Richard and Sharma, Dave and Selby, Colin and Morrison, David S and Docherty, Kirsty and McIntosh, David and McElhinney, Penny and Nicolson, Marianne and McMillan, Donald C and Milroy, Robert},
title = {Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response},
journal = {Lung Cancer International},
year = {2014},
doi = {10.1155/2014/731925}
}
EUVIMED